NxStage Voluntary Sak Recall
Higher levels of endotoxin than NxStage tolerates were found in less than 1% of affected sak lots, so they notified patients who had those lots and issued a voluntary recall. An FDA recall was not required.
Read the full article » | Posted 02-15-2018
Related Articles
- Update on H.R. 8875 “Improving Home Dialysis Act of 2026.” Posted 07-16-2026
- Stickman Industries Offers Many Products for Home Dialysis Patients Posted 07-16-2026
- Who Qualifies for Home Dialysis? Posted 07-16-2026
- NxStage’s ICan Tool Can Help HD Patients Learn to Self-cannulate Posted 07-16-2026

